诊断学理论与实践 ›› 2019, Vol. 18 ›› Issue (1): 56-60.doi: 10.16150/j.1671-2870.2019.01.011
收稿日期:
2018-09-20
出版日期:
2019-02-25
发布日期:
2019-02-25
通讯作者:
韩卫青
E-mail:hanweiqing2000@163.com
WEI Jian1, GAO Pingjin2, HAN Weiqing2()
Received:
2018-09-20
Online:
2019-02-25
Published:
2019-02-25
Contact:
HAN Weiqing
E-mail:hanweiqing2000@163.com
摘要: 目的 探讨α7烟碱型乙酰胆碱受体(α7 nicotinic acetylcholine receptor, α7 nAchR)与血管外膜成纤维细胞(adventitial fibroblasts, AF)表型转化间的关系。方法 选取雄性Sprague-Dawley(SD)大鼠,用组织切块法培养其胸主动脉外膜AF。为评估转化生长因子β1(transforming growth factor-β1, TGF-β1)刺激AF表型转化的作用,将体外培养的AF分为空白对照组A、TGF-β1处理24 h组和TGF-β1处理48 h组3组,处理结束后分别应用实时定量PCR和免疫印迹试验,检测相α7 nAchR基因和蛋白的表达以及α-肌动蛋白(α smooth muscle actin, α-SMA)和Ⅰ型胶原的表达情况。为进一步探讨α7 nAchR的激活能否抑制TGF-β1刺激表型转化及其分子机制,另将体外培养的AF分为空白对照组B、TGF-β1处理48 h组及TGF-β1处理48 h合并α7 nAchR激活剂PNU-282987处理组3组,处理48 h后用免疫印迹法检测α-SMA和Ⅰ型胶原的表达及细胞外调节蛋白激酶1/2(extracellular regulated protein kinases1/2, Erk1/2)磷酸化情况。结果 与空白对照A相比,TGF-β1可使α7 nAchR的基因和蛋白表达明显降低(P<0.05),同时TGF-β1可使α-SMA和Ⅰ型胶原的表达明显增加(P<0.05)。α7 nAchR激动剂PNU-282987可抑制TGF-β1刺激的AF中α-SMA和Ⅰ型胶原的表达,亦可抑制TGF-β1刺激的Erk1/2磷酸化。结论 α7 nAchR的抑制参与TGF-β1介导的血管AF表型转化,其机制可能与Erk1/2磷酸化有关。
中图分类号:
魏坚, 高平进, 韩卫青. α7烟碱型乙酰胆碱受体激动剂对TGF-β1介导的血管外膜成纤维细胞表型转化影响的体外研究[J]. 诊断学理论与实践, 2019, 18(1): 56-60.
WEI Jian, GAO Pingjin, HAN Weiqing. Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 56-60.
[1] | Mann T, Zilles K, Klawitter F, et al. Acetylcholine Neurotransmitter Receptor Densities in the Striatum of Hemiparkinsonian Rats Following Botulinum Neurotoxin-A Injection[J]. Front Neuroanat, 2018, 12:65. |
[2] | Carlisle DL, Hopkins TM, Gaither-Davis A, et al. Nicotine signals through muscle-type and neuronal nicotinic acetylcholine receptors in both human bronchial epithelial cells and airway fibroblasts[J]. Respir Res, 2004, 5:27. |
[3] | Ween H, Thorin-Hagene K, Andersen E, et al. Alpha3* and alpha 7 nAChR-mediated Ca2+ transient generation in IMR-32 neuroblastoma cells[J]. Neurochem Int, 2010, 57(3):269-277. |
[4] | Komal P, Gudavicius G, Nelson CJ, et al. T-cell receptor activation decreases excitability of cortical interneurons by inhibiting α7 nicotinic receptors[J]. J Neurosci, 2014, 34(1):22-35. |
[5] | Liu Q, Xie X, Emadi S, et al. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity[J]. Neuropharmacology, 2015, 97:457-63. |
[6] | Su X, Lee JW, Matthay ZA, et al. Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats[J]. Am J Respir Cell Mol Biol, 2007, 37(2):186-192. |
[7] | Liu Q, Liu C, Jiang L, et al. α 7 Nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation[J]. J Pain Res, 2018, 11:1129-1140. |
[8] | Li XW, Wang H. Non-neuronal nicotinic alpha 7 receptor, a new endothelial target for revascularization[J]. Life Sci, 2006, 78(16):1863-1870. |
[9] | Xu F, Liu Y, Shi L, et al. RGS 3 inhibits TGF-β1/Smad signalling in adventitial fibroblasts[J]. Cell Biochem Funct, 2017, 35(6):334-338. |
[10] | Xu JY, Chang NB, Li T, et al. Endothelial Cells Inhibit the Angiotensin II Induced Phenotypic Modulation of Rat Vascular Adventitial Fibroblasts[J]. J Cell Biochem, 2017, 118(7):1921-1927. |
[11] | Herrmann J, Samee S, Chade A, et al. Differential effect of experimental hypertension and hypercholesterolemia on adventitial remodeling[J]. Arterioscler Thromb Vasc Biol, 2005, 25(2):447-453. |
[12] | Sartore S, Chiavegato A, Faggin E, et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant[J]. Circ Res, 2001, 89(12):1111-1121. |
[13] | Coen M, Gabbiani G, Bochaton-Piallat ML. Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology[J]. Arterioscler Thromb Vasc Biol, 2011, 31(11):2391-2396. |
[14] | Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation[J]. Cardiovasc Res, 2007, 75(4):640-648. |
[15] | Forte A, Della Corte A, De Feo M, et al. Role of myofibroblasts in vascular remodelling: focus on restenosis and aneurysm[J]. Cardiovasc Res, 2010, 88(3):395-405. |
[16] | Kingston PA, Sinha S, David A, et al. Adenovirus-mediated gene transfer of a secreted transforming growth factor-beta type Ⅱ receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition[J]. Circulation, 2001, 104(21):2595-2601. |
[17] | Wildgruber M, Weiss W, Berger H, et al. Association of circulating transforming growth factor beta, tumor necrosis factor alpha and basic fibroblast growth factor with restenosis after transluminal angioplasty[J]. Eur J Vasc Endovasc Surg, 2007, 34(1):35-43. |
[18] | Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury[J]. Cardiovasc Res, 2007, 74(2):223-234. |
[19] | Gao PJ, Li Y, Sun AJ, et al. Differentiation of vascular myofibroblasts induced by transforming growth factor-beta1 requires the involvement of protein kinase Calpha[J]. J Mol Cell Cardiol, 2003, 35(9):1105-1112. |
[20] | Fleenor BS, Marshall KD, Durrant JR, et al. Arterial stiffening with ageing is associated with transforming growth factor-β1-related changes in adventitial collagen: reversal by aerobic exercise[J]. J Physiol, 2010, 588(Pt 20):3971-3982. |
[21] | Ren M, Wang B, Zhang J, et al. Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1[J]. Mol Med Rep, 2011, 4(3):561-567. |
[22] | Li X, Xu Y, Cheng Y, et al. α 7 Nicotinic acetylcholine receptor contributes to the alleviation of lung ischemia-reperfusion injury by transient receptor potential vanilloid type 1 stimulation[J]. J Surg Res, 2018, 230:164-174. |
[23] | Luo W, Liu X, Sun W, et al. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway[J]. Phytother Res, 2018, 32(10):2009-2020. |
[1] | 陈宏, 沈银忠. 人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534. |
[2] | 汤建平, 龚邦东. 干燥综合征的诊治现状、挑战和思考[J]. 诊断学理论与实践, 2022, 21(03): 291-298. |
[3] | 罗雅方, 徐倩玥, 余红. 尘螨在特应性皮炎中的致病机制及相关免疫治疗应用研究进展[J]. 诊断学理论与实践, 2021, 20(06): 592-595. |
[4] | 苏长青. 从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433. |
[5] | 章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232. |
[6] | 徐兆平, 王浩飞. ZNF692基因在肾透明细胞癌中的表达及其与患者预后间关系的研究[J]. 诊断学理论与实践, 2020, 19(03): 292-296. |
[7] | 余红, 王一飞, 陈佳, 陈洁, 李斌. 青蒿素及其衍生物在皮肤疾病中的作用机制研究及临床应用[J]. 诊断学理论与实践, 2019, 18(2): 233-236. |
[8] | 房莹, 吴东, 常春康. 癌基因与抑癌基因在伯基特淋巴瘤发生发展中的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 630-633. |
[9] | 徐婷婷, 张文. 感染与中性粒细胞胞质抗体相关性血管炎间相关性的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 698-703. |
[10] | 刘海霞, 瞿介明. 肺部微生态及其与肺癌关系的研究进展[J]. 诊断学理论与实践, 2019, 18(05): 496-502. |
[11] | 蔡业冰, 任家俊, 郝风节, 叶枫, 杨宇尘, 龚笑勇, 马迪, 王俊青, 陈拥军. 人类假基因在以肝癌为主的肿瘤中的作用及研究进展[J]. 诊断学理论与实践, 2019, 18(05): 590-594. |
[12] | 周敏, 张秋蕊. 呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响[J]. 诊断学理论与实践, 2019, 18(03): 246-249. |
[13] | 时国朝, 黄春容. 呼吸道及肠道微生物菌群与支气管哮喘的发病及治疗[J]. 诊断学理论与实践, 2019, 18(03): 241-245. |
[14] | 蒋晓飞, 周迎. 碳青霉烯耐药肺炎克雷伯菌的耐药与传播机制研究进展及对策[J]. 诊断学理论与实践, 2018, 17(06): 623-629. |
[15] | 张梦雪, 王小钦. 铁稳态失调相关的炎症性贫血发病机制及诊断进展[J]. 诊断学理论与实践, 2018, 17(05): 601-605. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||